But eczema is the name for a group of skin conditions. They all cause red, itchy, and often cracked skin, but each type has its own unique symptoms as well. Learn more about the various types of ...

As a student, Mr David Low* made every effort to take part in physical education lessons, but eczema flare-ups often kept him ...

London hospital launches study to prevent food allergies through eczema treatment - Results of study could have ‘hugely ...

Among the great array of skin disorders the symptoms of eczema stand as commonplace and almost every day disorder. Eczema contrary to popular beliefs and widespread misconceptions is not just a ...

The condition is chronic, but it typically responds well to treatment. While the exact cause of nummular eczema is unknown, certain risk factors and triggers can increase your chances of ...

Home remedies, topical creams, and dietary changes may be enough to treat itchy blisters on your feet from dyshidrotic eczema. A doctor may also prescribe medications or other therapies.

with moderate-to-severe eczema who could not control their symptoms with topical prescription medicines. The primary endpoint for these studies was evaluated at 16 weeks and measured clear or ...

Eli Lilly said the Food and Drug Administration approved its treatment for moderate-to-severe eczema that isn't well controlled despite treatment with topical prescription therapies. The treatment ...

INDIANAPOLIS–The U.S. Food and Drug Administration has approved Indianapolis-based Eli Lilly’s new treatment for moderate to severe eczema. It’s called Ebglyss. Ebglyss is used as an injection.

with moderate-to-severe atopic dermatitis (eczema) that is not well controlled despite treatment with topical prescription therapies. Ebglyss works by targeting eczema inflammation throughout the ...

Lilly hopes to challenge Regeneron and Sanofi’s dominant IL-4/IL-13 treatment in the indication, Dupixent. Another IL-13 on the market for AD is Leo Pharma’s Adbry, which was launched in 2022.